Advertisement

Loading...

Anteris Technologies Ltd

AVR.AXASX
Healthcare
Medical - Devices
$7.55
$0.25(3.42%)
Australian Market opens in 16h 32m

Anteris Technologies Ltd Fundamental Analysis

Anteris Technologies Ltd (AVR.AX) shows moderate financial fundamentals with a PE ratio of -2.09, profit margin of -49.21%, and ROE of -7.74%. The company generates $0.0B in annual revenue with moderate year-over-year growth of 6.23%.

Key Strengths

PEG Ratio-0.11

Areas of Concern

ROE-7.74%
Operating Margin-49.08%
Cash Position4.43%
Current Ratio0.73
We analyze AVR.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -4191.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-4191.7/100

We analyze AVR.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

AVR.AX struggles to generate sufficient returns from assets.

ROA > 10%
-4.09%

Valuation Score

Excellent

AVR.AX trades at attractive valuation levels.

PE < 25
-2.09
PEG Ratio < 2
-0.11

Growth Score

Moderate

AVR.AX shows steady but slowing expansion.

Revenue Growth > 5%
6.23%
EPS Growth > 10%
-41.30%

Financial Health Score

Moderate

AVR.AX shows balanced financial health with some risks.

Debt/Equity < 1
-24.54
Current Ratio > 1
0.73

Profitability Score

Weak

AVR.AX struggles to sustain strong margins.

ROE > 15%
-774.43%
Net Margin ≥ 15%
-49.21%
Positive Free Cash Flow
No

Key Financial Metrics

Is AVR.AX Expensive or Cheap?

P/E Ratio

AVR.AX trades at -2.09 times earnings. This suggests potential undervaluation.

-2.09

PEG Ratio

When adjusting for growth, AVR.AX's PEG of -0.11 indicates potential undervaluation.

-0.11

Price to Book

The market values Anteris Technologies Ltd at -2114.24 times its book value. This may indicate undervaluation.

-2114.24

EV/EBITDA

Enterprise value stands at -2.28 times EBITDA. This is generally considered low.

-2.28

How Well Does AVR.AX Make Money?

Net Profit Margin

For every $100 in sales, Anteris Technologies Ltd keeps $-49.21 as profit after all expenses.

-49.21%

Operating Margin

Core operations generate -49.08 in profit for every $100 in revenue, before interest and taxes.

-49.08%

ROE

Management delivers $-7.74 in profit for every $100 of shareholder equity.

-7.74%

ROA

Anteris Technologies Ltd generates $-4.09 in profit for every $100 in assets, demonstrating efficient asset deployment.

-4.09%

Following the Money - Real Cash Generation

Operating Cash Flow

Anteris Technologies Ltd generates limited operating cash flow of $-38.83M, signaling weaker underlying cash strength.

$-38.83M

Free Cash Flow

Anteris Technologies Ltd generates weak or negative free cash flow of $-39.78M, restricting financial flexibility.

$-39.78M

FCF Per Share

Each share generates $-1.08 in free cash annually.

$-1.08

FCF Yield

AVR.AX converts -19.42% of its market value into free cash.

-19.42%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-2.09

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.11

vs 25 benchmark

P/B Ratio

Price to book value ratio

-2114.24

vs 25 benchmark

P/S Ratio

Price to sales ratio

104.85

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-24.54

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.73

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-7.74

vs 25 benchmark

ROA

Return on assets percentage

-4.09

vs 25 benchmark

ROCE

Return on capital employed

-57.82

vs 25 benchmark

How AVR.AX Stacks Against Its Sector Peers

MetricAVR.AX ValueSector AveragePerformance
P/E Ratio-2.0928.31 Better (Cheaper)
ROE-774.43%699.00% Weak
Net Margin-4921.28%-130884.00% (disorted) Weak
Debt/Equity-24.540.34 Strong (Low Leverage)
Current Ratio0.732775.16 Weak Liquidity
ROA-409.38%-14469.00% (disorted) Weak

AVR.AX outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Anteris Technologies Ltd's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-82.55%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-1345.04%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-195.21%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ